The post Full List of Ripple’s Partnerships After XRP Regulatory Victory appeared first on Coinpedia Fintech News In March 2025, Ripple CEO Brad Garlinghouse announced the conclusion of the SEC case, confirming that XRP is not considered a security for public exchange sales, but remains one for institutional sales. After this regulatory clarity, Ripple formed new partnerships with several banks and financial institutions. The SEC officially closed its lawsuit against Ripple Labs …The post Full List of Ripple’s Partnerships After XRP Regulatory Victory appeared first on Coinpedia Fintech News In March 2025, Ripple CEO Brad Garlinghouse announced the conclusion of the SEC case, confirming that XRP is not considered a security for public exchange sales, but remains one for institutional sales. After this regulatory clarity, Ripple formed new partnerships with several banks and financial institutions. The SEC officially closed its lawsuit against Ripple Labs …

Full List of Ripple’s Partnerships After XRP Regulatory Victory

2025/09/25 13:20
Ripple

The post Full List of Ripple’s Partnerships After XRP Regulatory Victory appeared first on Coinpedia Fintech News

In March 2025, Ripple CEO Brad Garlinghouse announced the conclusion of the SEC case, confirming that XRP is not considered a security for public exchange sales, but remains one for institutional sales. After this regulatory clarity, Ripple formed new partnerships with several banks and financial institutions. The SEC officially closed its lawsuit against Ripple Labs over unregistered securities, keeping a $125 million penalty in place and ending one of the most closely watched legal cases in the cryptocurrency world.

List of Major Ripple Partnerships

  • BNY Mellon: In July 2025, Ripple appointed the Bank of New York as the primary custodian for Ripple’s U.S. dollar-pegged stablecoin, Ripple USD (RLUSD).
  • Hidden Road: In April 2025, Ripple acquired prime brokerage firm Hidden Road for $1.25 billion. The acquisition aims to strengthen Ripple’s position in bridging traditional finance and digital assets, controlling key transaction rails, leveraging the XRP Ledger (XRPL) for institutional services, and integrating RLUSD as collateral.
  • Dubai Land Department & Ctrl Alt: In July 2025, Ripple partnered with these organizations to support the tokenization of real estate on the XRP Ledger.
  • Canadian Imperial Bank of Commerce (CIBC), Canada: The alliance, initially formed in 2016, expanded in July 2025. CIBC provided growth capital financing to Ripple Operations, a company focused on crew success technology for the maritime industry.
  • SBI Remit & SBI Holdings, Japan: In August 2025, SBI signed a Memorandum of Understanding (MOU) with Ripple and SBI VC Trade to introduce Ripple’s U.S. dollar-backed stablecoin, RLUSD, to the Japanese market by 2026.

Ripple Expands Global Collaborations

Overall, Ripple has partnered with more than 100 financial institutions globally and continues to expand. Using RippleNet technology and the XRP Ledger, it enables fast and efficient cross-border payments.

Some companies, like South Korea’s digital asset custodian BDACS, partnered with Ripple before the SEC ruling. After regulatory clarity, BDACS began offering XRP custody services in August 2025. With compliant infrastructure, rising demand, and clear regulations, Ripple is thriving.

Ripple also applied to the Office of the Comptroller of the Currency (OCC) for national trust bank charters in July 2025. This will allow Ripple to operate federally chartered banks, gain legitimacy, operate across state lines, and hold stablecoin reserves with direct access to the Federal Reserve’s payment infrastructure.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29